# SOLOSEC
> **NDA209363** · New Drug Application · Sponsor: EVOFEM INC · Approved 2017-09-15
## Drug
- **FDA Application Number:** NDA209363
- **Application type:** New Drug Application
- **Brand name:** SOLOSEC
- **Generic name:** SECNIDAZOLE
- **Active ingredients:** SECNIDAZOLE
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EVOFEM INC
- **Manufacturer:** Evofem Inc.
- **First approval:** 2017-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209363)
---
*AI Analytics · CC0 1.0*